Summary
Polyphor Ltd. (Polyphor) is a research-oriented pharmaceutical company that discovers and develops macrocyclic drugs that address high unmet medical needs. Its product portfolio encompasses indications for the transplantation of hematopoietic stem cells especially in multiple myeloma patients; Pseudomonas infections; and protease inhibitor for chronic obstructive pulmonary disease, alpha-1-antitrypsin deficiency, cystic fibrosis and other lung diseases. Polyphor’s proprietary technology platforms include MacroFinder and PEMfinder that are used to discover the potent and selective modulators of protein-protein interactions and other challenging targets. It employs its unique technologies for collaborating and licensing with other pharma companies. Polyphor is headquartered in Basel, Switzerland.
Polyphor Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Polyphor Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Polyphor Ltd., Medical Devices Deals, 2010 to YTD 2016 9
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Polyphor Ltd., Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Polyphor Enters into Research Agreement with Taisho Pharma 11
Axxam Enters Into Co-Development Agreement With Polyphor 12
Polyphor Expands Drug Discovery Agreement with Novartis 13
Polyphor Enters Into Co-Development Agreement With Axxam 14
Polyphor Enters Into Collaboration Agreement With University of Zurich 16
Licensing Agreements 17
Roche Terminates Licensing Agreement with Polyphor for POL-7080 17
Polyphor Enters Into Licensing Agreement With Boehringer Ingelheim For MacroFinder Drug Discovery Technology 19
Equity Offering 21
Polyphor May Raise Funds through IPO 21
Acquisition 22
Bachem Sells 16% Stake In Polyphor To Ingro Finanz 22
Polyphor Ltd. - Key Competitors 23
Key Employees 24
Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26
List of Tables
Polyphor Ltd., Pharmaceuticals & Healthcare, Key Facts 1
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Polyphor Ltd., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Polyphor Ltd., Deals By Therapy Area, 2010 to YTD 2016 8
Polyphor Ltd., Medical Devices Deals, 2010 to YTD 2016 9
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Polyphor Enters into Research Agreement with Taisho Pharma 11
Axxam Enters Into Co-Development Agreement With Polyphor 12
Polyphor Expands Drug Discovery Agreement with Novartis 13
Polyphor Enters Into Co-Development Agreement With Axxam 14
Polyphor Enters Into Collaboration Agreement With University of Zurich 16
Roche Terminates Licensing Agreement with Polyphor for POL-7080 17
Polyphor Enters Into Licensing Agreement With Boehringer Ingelheim For MacroFinder Drug Discovery Technology 19
Polyphor May Raise Funds through IPO 21
Bachem Sells 16% Stake In Polyphor To Ingro Finanz 22
Polyphor Ltd., Key Competitors 23
Polyphor Ltd., Key Employees 24
List of Figures
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Polyphor Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Polyphor Ltd., Medical Devices Deals, 2010 to YTD 2016 9